FCBT
CYTK icon

First Citizens Bank & Trust’s Cytokinetics CYTK Stock Holding History

First Citizens Bank & Trust’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-9,838
Closed -$204K – 394
2020
Q4 		$204K Sell
9,838
-2,401
-20% -$43.9K 0.01% 355
2020
Q3 		$265K Sell
12,239
-306
-2% -$7.16K 0.02% 276
2020
Q2 		$296K Sell
12,545
-5,304
-30% -$99.5K 0.02% 253
2020
Q1 		$210K Buy
17,849
+3,533
+25% +$45.1K 0.03% 275
2019
Q4 		$152K Sell
14,316
-1,486
-9% -$15.3K 0.01% 361
2019
Q3 		$180K Sell
15,802
-151
-0.9% -$1.9K 0.02% 357
2019
Q2 		$179K Sell
15,953
-358
-2% -$3.45K 0.02% 409
2019
Q1 		$132K Buy
+16,311
New +$120K 0.01% 399

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

First Citizens Bank & Trust's CYTK Position: Q1 2021 in Review

First Citizens Bank & Trust sold out of Cytokinetics (CYTK) in Q1 2021, closing a stake of 9,838 shares — an estimated $204K sold.

First Citizens Bank & Trust first reported a position in CYTK in Q1 2019 and held it in 8 quarters. The position peaked at $296K in Q2 2020. 192 funds tracked by Wall St. Rank hold CYTK as of Q1 2021.

  • First Citizens Bank & Trust reported no remaining Cytokinetics position as of Q1 2021 after selling out during the quarter.
  • First Citizens Bank & Trust sold 9,838 Cytokinetics shares in Q1 2021, an estimated $204K.
  • First Citizens Bank & Trust first reported a position in Cytokinetics in Q1 2019 and held it in 8 quarters.
  • First Citizens Bank & Trust's Cytokinetics position peaked at $296K in Q2 2020.
  • 192 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2021.

Based on First Citizens Bank & Trust's 13F filing for Q1 2021, filed 14 Apr 2021.